LNO

Welcome to the Brand page for “LNO”, which is offered here for Apparatuses for the culture of, immunization of, and harvesting of synthetic cells, tissues and organoids, tissue culture plates, cell culture plates, tissue culture flasks, cell culture flasks, and tissue culture on a chip with media reservoirs;pharmaceutical preparations for use in 3d bioprinting of tissues and organs that are intended for transplant purposes to replace diseased or failing tissues and organs; pharmaceutical preparations for the treatment and prevention of immune diseases, cancers and tumors namely monoclonal antibodies and antibody derived therapeutics, cellular therapeutics, and vaccines for use in the field immunology, autoimmunity, and oncology; pharmaceutical preparations namely, antivirals, immunopharmaceuticals, and monoclonal antibodies for use in the fields of viral related diseases and disorders; pharmaceutical preparations for use in the field of tissue engineering to produce engineered biological tissues and tissue arrays for use in transplants to replace diseases or failing tissues;cell culture media in the nature of synthetic cell culture scaffolds for use in scientific, pharmaceutical and medical research; cell culture media in the nature of synthetic cell culture scaffolds for use in tissue engineering; engineered biological tissues and tissue arrays for use in scientific, pharmaceutical and medical research; engineered biological tissues and tissue arrays for use in tissue engineering;.

Its status is currently believed to be active. Its class is unavailable. “LNO” is believed to be currently owned by “Prellis Biologics, Inc.”

Owner:
PRELLIS BIOLOGICS, INC.
Owner Details
Description:
Apparatuses for the culture of, immunization of, and harvesting of synthetic cells, tissues and organoids, tissue culture plates, cell culture plates, tissue culture flasks, cell culture flasks, and tissue culture on a chip with media reservoirs;Pharmaceutical preparations for use in 3D bioprinting of tissues and organs that are intended for transplant purposes to replace diseased or failing tissues and organs; pharmaceutical preparations for the treatment and prevention of immune diseases, cancers and tumors namely monoclonal antibodies and antibody derived therapeutics, cellular therapeutics, and vaccines for use in the field immunology, autoimmunity, and oncology; pharmaceutical preparations namely, antivirals, immunopharmaceuticals, and monoclonal antibodies for use in the fields of viral related diseases and disorders; pharmaceutical preparations for use in the field of tissue engineering to produce engineered biological tissues and tissue arrays for use in transplants to replace diseases or failing tissues;Cell culture media in the nature of synthetic cell culture scaffolds for use in scientific, pharmaceutical and medical research; cell culture media in the nature of synthetic cell culture scaffolds for use in tissue engineering; engineered biological tissues and tissue arrays for use in scientific, pharmaceutical and medical research; engineered biological tissues and tissue arrays for use in tissue engineering;
Categories: APPARATUSES CULTURE